Anne Flanigan

1.1k total citations · 1 hit paper
12 papers, 970 citations indexed

About

Anne Flanigan is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Anne Flanigan has authored 12 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Anne Flanigan's work include Inflammatory Bowel Disease (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Microscopic Colitis (3 papers). Anne Flanigan is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Microscopic Colitis (3 papers). Anne Flanigan collaborates with scholars based in United States. Anne Flanigan's co-authors include Sreekant Murthy, Mitchell A. Lazar, Shannon T. Bailey, Shamina M. Rangwala, Xiaoming Wen, Gary D. Wu, Wen G. Jiang, Chinyu Su, Sue A. Keilbaugh and S. Murthy and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anne Flanigan

10 papers receiving 947 citations

Hit Papers

A novel therapy for colit... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Flanigan United States 5 581 222 206 205 190 12 970
Teresa G. Tessner United States 16 486 0.8× 257 1.2× 339 1.6× 140 0.7× 259 1.4× 16 1.3k
Ann H. Rosendahl Sweden 19 486 0.8× 156 0.7× 179 0.9× 251 1.2× 112 0.6× 55 1.2k
C. Richard Boland United States 12 615 1.1× 68 0.3× 135 0.7× 318 1.6× 98 0.5× 28 1.1k
S. Blades United Kingdom 7 229 0.4× 193 0.9× 113 0.5× 190 0.9× 125 0.7× 7 917
Hisataka Moriwaki Japan 17 496 0.9× 160 0.7× 164 0.8× 170 0.8× 82 0.4× 28 1.2k
Rebecca Mar United States 7 270 0.5× 261 1.2× 272 1.3× 87 0.4× 215 1.1× 7 984
Jianting Cai China 20 338 0.6× 102 0.5× 305 1.5× 238 1.2× 93 0.5× 62 1.0k
Lei Zhu China 18 609 1.0× 135 0.6× 78 0.4× 149 0.7× 245 1.3× 58 1.0k
Kazuya Hata Japan 17 413 0.7× 73 0.3× 111 0.5× 171 0.8× 109 0.6× 23 935

Countries citing papers authored by Anne Flanigan

Since Specialization
Citations

This map shows the geographic impact of Anne Flanigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Flanigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Flanigan more than expected).

Fields of papers citing papers by Anne Flanigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Flanigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Flanigan. The network helps show where Anne Flanigan may publish in the future.

Co-authorship network of co-authors of Anne Flanigan

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Flanigan. A scholar is included among the top collaborators of Anne Flanigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Flanigan. Anne Flanigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Myers, Kathleen, Sreekant Murthy, Anne Flanigan, et al.. (2003). Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis. Journal of Pharmacology and Experimental Therapeutics. 304(1). 411–424. 78 indexed citations
2.
Murthy, Sreekant, Anne Flanigan, & Harris R. Clearfield. (2003). Colorectal cancer in inflammatory bowel disease: molecular and clinical features. Hematology/Oncology Clinics of North America. 17(2). 525–537. 1 indexed citations
3.
Murthy, Sreekant, Anne Flanigan, & Harris R. Clearfield. (2002). Colorectal cancer in inflammatory bowel disease: molecular and clinical features. Gastroenterology Clinics of North America. 31(2). 551–564. 8 indexed citations
4.
Murthy, Sudha, Anne Flanigan, Domenico Coppola, & Roland Buelow. (2002). RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis. Inflammation Research. 51(11). 522–531. 33 indexed citations
5.
Flanigan, Anne, et al.. (2001). Inhibition of DSS-induced colitis by TZD ligands for PPARγis dependent on T-lymphocytes. Gastroenterology. 120(5). A693–A693. 1 indexed citations
7.
8.
Su, Chinyu, Xiaoming Wen, Shannon T. Bailey, et al.. (1999). A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. Journal of Clinical Investigation. 104(4). 383–389. 665 indexed citations breakdown →
10.
Murthy, Sreekant, et al.. (1998). Inflammatory bowel diseases: a new wave of therapy. Expert Opinion on Therapeutic Patents. 8(7). 785–818. 1 indexed citations
11.
Flanigan, Anne, et al.. (1998). The response of IL-1β-converting enzyme (ICE)-deficient mice to dextran sulfate (DSS). Gastroenterology. 114. A1047–A1047. 1 indexed citations
12.
Murthy, Sreekant & Anne Flanigan. (1997). Recent developments in inflammatory bowel disease therapy. Expert Opinion on Therapeutic Patents. 7(7). 695–715. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026